Skip Navigation

Skip Navigation

Issue No. 29  | July 13, 2012
View HTML version

AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of HIV/AIDS news useful.

Globe of the earth

Leading NIH Researchers to Discuss Key Research Challenges at the International AIDS Conference

NIH researchers will discuss some of the key AIDS research challenges at the XIX International AIDS Conference (AIDS 2012). The interactive satellite discussion entitled “New Frontiers in NIH AIDS Research” will be presented on the opening day of the conference, Sunday, July 22, from 11:15 a.m. to 1:15 p.m.

AIDS 2012 extends through Friday, July 27. Throughout the week, NIH-supported scientists will present additional research illuminating progress and challenges in AIDS prevention and treatment and the search for a cure for HIV infection.

More information is available from NIH:

  • Webpage highlighting the “New Frontiers in NIH AIDS Research” satellite discussion
  • Media advisory and NIH webpage on NIH activities at AIDS 2012


NIH Awards Funding for New Centers for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID)

“Duke University of Durham, N.C., and the Scripps Research Institute of La Jolla, Calif., have been awarded $31 million in first-year funding to lead the new Centers for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID). The funding is from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. …

“The goal is to accelerate HIV vaccine development by supporting multidisciplinary research into immune responses that prevent or contain HIV infection and generating model vaccine components that can induce these protective immune responses.

“CHAVI-ID, a consortium of researchers at universities and academic medical centers, will build on advances made in several laboratories, including the Center for HIV/AIDS Vaccine Immunology (CHAVI), based at Duke University.”

More information is available:


Twitter - Stay connected FaceBook - Stay connected
ClinicalTrials.gov Info

Subscribe Info

Contact AIDSinfo
Download Adobe Acrobat(R) Reader TM to view PDF files located on this site.
ISSN 1558-3228